|
gptkbp:instanceOf
|
gptkb:inhalational_anesthetic
gptkb:halogenated_ether
|
|
gptkbp:aroma
|
pungent
|
|
gptkbp:ATCCode
|
N01AB07
|
|
gptkbp:blood/gas_partition_coefficient
|
0.42
|
|
gptkbp:boilingPoint
|
23.5 °C
|
|
gptkbp:brand
|
Suprane
|
|
gptkbp:CASNumber
|
57041-67-5
|
|
gptkbp:chemicalFormula
|
C3H2F6O
|
|
gptkbp:color
|
colorless
|
|
gptkbp:contraindication
|
malignant hyperthermia
known hypersensitivity
|
|
gptkbp:discoveredBy
|
gptkb:Ross_Terrell
|
|
gptkbp:effect
|
gptkb:center
muscle relaxation
analgesia
decreased blood pressure
rapid induction and emergence
|
|
gptkbp:eliminatedIn
|
exhalation
|
|
gptkbp:environmentalImpact
|
gptkb:greenhouse_gas
|
|
gptkbp:introducedIn
|
1992
|
|
gptkbp:IUPACName
|
2-(difluoromethoxy)-1,1,1,2-tetrafluoroethane
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Baxter_International
|
|
gptkbp:metabolism
|
minimal (0.02%)
|
|
gptkbp:minimum_alveolar_concentration_(MAC)
|
6.0% (in adults)
|
|
gptkbp:molecularWeight
|
168.04 g/mol
|
|
gptkbp:notRecommendedFor
|
induction in children
|
|
gptkbp:PubChem_CID
|
42113
DB01189
|
|
gptkbp:relatedTo
|
gptkb:enflurane
gptkb:isoflurane
sevoflurane
|
|
gptkbp:routeOfAdministration
|
inhalation
|
|
gptkbp:sideEffect
|
hypotension
tachycardia
airway irritation
|
|
gptkbp:solubility_in_blood
|
very low
|
|
gptkbp:storage
|
special vaporizer required
|
|
gptkbp:UNII
|
T8G1HKL98O
|
|
gptkbp:used_in
|
operating rooms
outpatient surgery
general anesthesia
|
|
gptkbp:usedFor
|
induction of anesthesia
maintenance of anesthesia
|
|
gptkbp:vapor_pressure_at_20°C
|
669 mmHg
|
|
gptkbp:bfsParent
|
gptkb:Post_Anesthesia_Emergence_Delirium
gptkb:Norflurane
|
|
gptkbp:bfsLayer
|
8
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
desflurane
|